New Company Aims to Cure Rare Illness
A company called Werewolf now joins Ambros to help patients with a rare liver disease move closer to a cure.
A new medicine could soon help people with a rare liver disease. This medicine comes from Ambros Therapeutics. It aims to treat Wilson's Disease. This illness makes too much copper build up in the body. It can cause serious health problems. Ambros wants to get this new medicine approved quickly.
To make this happen, Ambros merged with another company, Werewolf Therapeutics. This deal helps Ambros get more money. They raised $150 million. This money will pay for important tests for the medicine. These tests are the last step before asking for approval. Many patients hope for this new treatment.
Ambros is now working hard on its medicine, AMB-061. This medicine is already in its final testing stage. If the tests go well, Ambros can ask for approval. This could bring a new way to help people with Wilson's Disease. This news is good for many patients waiting for better options.
Source: FierceBiotech
More from Biotech
